Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families

[1]  Ahmed M. Hagag,et al.  Prospective deep phenotyping of choroideremia patients using multimodal structure-function approaches , 2020, Eye.

[2]  K. Tsunoda,et al.  Novel homozygous CLN3 missense variant in isolated retinal dystrophy: A case report and electron microscopic findings , 2020, Molecular genetics & genomic medicine.

[3]  K. Tsunoda,et al.  RDH5-Related Fundus Albipunctatus in a Large Japanese Cohort , 2020, Investigative ophthalmology & visual science.

[4]  R. Sui,et al.  CLINICAL CHARACTERISTICS AND MOLECULAR GENETIC ANALYSIS OF A COHORT OF CHINESE PATIENTS WITH CHOROIDEREMIA. , 2020, Retina.

[5]  P. Melillo,et al.  CHM/REP1 Transcript Expression and Loss of Visual Function in Patients Affected by Choroideremia. , 2019, Investigative Ophthalmology and Visual Science.

[6]  K. Tsunoda,et al.  High-Resolution Retinal Imaging Reveals Preserved Cone Photoreceptor Density and Choroidal Thickness in Female Carriers of Choroideremia. , 2019, Ophthalmic surgery, lasers & imaging retina.

[7]  W. Feuer,et al.  Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results. , 2019, American journal of ophthalmology.

[8]  I. MacDonald,et al.  Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience. , 2018, American journal of ophthalmology.

[9]  M.,et al.  Changes [I] , 2018, The Complete Poems of William Barnes, Vol. 2: Poems in the Modified Form of the Dorset Dialect.

[10]  K. Yamaki,et al.  CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family , 2018, Ophthalmic genetics.

[11]  Cristina Has,et al.  Faculty of 1000 evaluation for Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. , 2018 .

[12]  A. Bergen,et al.  LONG-TERM FOLLOW-UP OF PATIENTS WITH CHOROIDEREMIA WITH SCLERAL PITS AND TUNNELS AS A NOVEL OBSERVATION , 2017, Retina.

[13]  B. Wilhelm,et al.  CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA. , 2018, Retina.

[14]  R. Sui,et al.  Rep1 copy number variation is an important genetic cause of choroideremia in Chinese patients , 2017, Experimental eye research.

[15]  E. McDonagh,et al.  Single‐base substitutions in the CHM promoter as a cause of choroideremia , 2017, Human mutation.

[16]  Takaaki Hayashi,et al.  Closure of a full‐thickness macular hole without vitrectomy in choroideraemia , 2017, Clinical & experimental optometry.

[17]  Emily S. Charlson,et al.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study. , 2017, Ophthalmology.

[18]  K. Xue,et al.  The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype , 2016, Investigative ophthalmology & visual science.

[19]  Susan M. Downes,et al.  A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia , 2016, Investigative ophthalmology & visual science.

[20]  A. V. Cideciyan,et al.  Visual Function and Central Retinal Structure in Choroideremia. , 2016, Investigative ophthalmology & visual science.

[21]  G. Holder,et al.  Visual Acuity after Retinal Gene Therapy for Choroideremia. , 2016, The New England journal of medicine.

[22]  C. Rivolta,et al.  A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice , 2016, PloS one.

[23]  I. MacDonald,et al.  Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy , 2016, Molecular genetics & genomic medicine.

[24]  B. Wilhelm,et al.  Multimodal assessment of choroideremia patients defines pre-treatment characteristics , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[25]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[26]  F. Cremers,et al.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.

[27]  G. Hall,et al.  A clinical molecular genetic service for United Kingdom families with choroideraemia. , 2013, European journal of medical genetics.

[28]  E. Traboulsi,et al.  Choroideremia: A review of general findings and pathogenesis , 2012, Ophthalmic genetics.

[29]  E. Traboulsi,et al.  Choroideremia: Effect of age on visual acuity in patients and female carriers , 2012, Ophthalmic genetics.

[30]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[31]  I. MacDonald,et al.  The functional effect of pathogenic mutations in Rab escort protein 1. , 2009, Mutation research.

[32]  M. Preising,et al.  Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview , 2004, Ophthalmic genetics.

[33]  H. Brunner,et al.  Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon , 2003, Human Genetics.

[34]  D. K. Roberts,et al.  Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia , 2002, The British journal of ophthalmology.

[35]  A. Murakami,et al.  REP-1 gene mutations in Japanese patients with choroideremia , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[36]  E. Kominami,et al.  Visual impairment and REP-1 gene mutations in Japanese choroideremia patients. , 1999, Ophthalmic genetics.

[37]  F. Cremers,et al.  Cloning and characterization of the human choroideremia gene. , 1994, Human molecular genetics.

[38]  M. Brown,et al.  Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase. , 1993, Science.

[39]  E. Zrenner,et al.  Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. , 1992, American journal of human genetics.

[40]  A. Chapelle,et al.  Aberrant splicing of the CHM gene is a significant cause of choroideremia , 1992, Nature Genetics.

[41]  R. Nussbaum,et al.  Isolation of a candidate gene for choroideremia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Cremers,et al.  Cloning of a gene that is rearranged in patients with choroideraemia , 1990, Nature.

[43]  H. Palmer,et al.  The Alberta Experience , 1982 .